Insights
Notes on skin, technology, and formula.
What we keep on the desk: how an active is screened, how a skincare product is carried, and why a claim must wait for the formula.
Studio
From this bench.
Four short readings on screening, delivery technology, production, and the line between skincare products and medicine.
A formula is named only after the material has been read
Dermatology and chemistry share the same table before anything is allowed to become a claim.
Field notes
BioAlps news
Dispatches from the wider life-sciences field, kept for context.
Bearmind takes a WIPO Global Award
Actival at the venture 2026 awards
Bioscibex ships its first bioreactors
BIND 2026 names four from the Health Valley
A biotools table for the Health Valley
Syrhatech Completes A CHF 4.5 Million Financing Round
TOP 100 Swiss Startup Award
NewBiologix Licences Xcell-Eng-HEK293 Cell Line to Recipharm
Theia Holding SA Merges With HL Technology SA
Hedera Dx Secures €15 Million Series A
Timeline Named Milestone 1 Award Winner in XPRIZE Healthspan Competition
Archive
BioAlps 20 years
The original twentieth-year series, with five later readings kept beside it.
BioAlps, reread | BioArk
BioAlps, reread | CSL Behring
BioAlps, reread | OM Pharma
BioAlps, reread | SILAB
BioAlps, reread | Debiopharm
BioAlps | 20 years of innovation | OM Pharma
BioAlps | 20 years of innovation | Debiopharm
BioAlps | 20 years of innovation | Ichnos
BioAlps | 20 years of innovation | Pharmalp
BioAlps | 20 years of innovation | CSL Behring
BioAlps | 20 years of innovation | Vifor Pharma
BioAlps | 20 years of innovation | BioArk
BioAlps | 20 years of innovation | HES-SO
BioAlps | 20 years of innovation | Fongit
